BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29459017)

  • 21. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands.
    Koëter M; Parry K; Verhoeven RH; Luyer MD; Ruurda JP; van Hillegersberg R; Lemmens VE; Nieuwenhuijzen GA
    Ann Surg Oncol; 2016 May; 23(5):1632-8. PubMed ID: 26727917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anastomotic leak predicts diminished long-term survival after resection for gastric and esophageal cancer.
    Andreou A; Biebl M; Dadras M; Struecker B; Sauer IM; Thuss-Patience PC; Chopra S; Fikatas P; Bahra M; Seehofer D; Pratschke J; Schmidt SC
    Surgery; 2016 Jul; 160(1):191-203. PubMed ID: 27067160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Extent of radical surgery in cardia carcinoma--esophagectomy or gastrectomy?].
    Hölscher AH; Bollschweiler E; Beckurts KT; Siewert JR
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():169-72. PubMed ID: 9101821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiorespiratory fitness assessment and prediction of peak oxygen consumption by Incremental Shuttle Walking Test in healthy women.
    Lima LP; Leite HR; Matos MA; Neves CDC; Lage VKDS; Silva GPD; Lopes GS; Chaves MGA; Santos JNV; Camargos ACR; Figueiredo PHS; Lacerda ACR; Mendonça VA
    PLoS One; 2019; 14(2):e0211327. PubMed ID: 30730949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do we need a practice incremental shuttle walk test for patients with interstitial lung disease referred for pulmonary rehabilitation?
    Johnson-Warrington V; Sewell L; Morgan M; Singh S
    Respirology; 2015 Apr; 20(3):434-8. PubMed ID: 25615527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenocarcinoma of the esophago-gastric junction.
    Siewert JR; Stein HJ; Feith M
    Scand J Surg; 2006; 95(4):260-9. PubMed ID: 17249275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertension.
    Billings CG; Hurdman JA; Condliffe R; Elliot CA; Smith IA; Austin M; Armstrong IJ; Hamilton N; Charalampopoulos A; Sabroe I; Swift AJ; Rothman AM; Wild JM; Lawrie A; Waterhouse JC; Kiely DG
    J Heart Lung Transplant; 2017 Aug; 36(8):871-879. PubMed ID: 28579006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incremental shuttle walking test: a reproducible and valid test to evaluate exercise tolerance in adults with noncystic fibrosis bronchiectasis.
    de Camargo AA; Amaral TS; Rached SZ; Athanazio RA; Lanza FC; Sampaio LM; de Carvalho CR; Cukier A; Stelmach R; Dal Corso S
    Arch Phys Med Rehabil; 2014 May; 95(5):892-9. PubMed ID: 24361325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia.
    Hagen JA; Peters JH; DeMeester TR
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):850-8; discussion 858-9. PubMed ID: 8231207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
    van der Veen A; Seesing MFJ; Wijnhoven BPL; de Steur WO; van Berge Henegouwen MI; Rosman C; van Sandick JW; Mook S; Haj Mohammad N; Ruurda JP; Brosens LAA; van Hillegersberg R;
    Eur J Surg Oncol; 2018 Dec; 44(12):1955-1962. PubMed ID: 30201419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peak exercise capacity estimated from incremental shuttle walking test in patients with COPD: a methodological study.
    Arnardóttir RH; Emtner M; Hedenström H; Larsson K; Boman G
    Respir Res; 2006 Oct; 7(1):127. PubMed ID: 17044921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.
    Springfeld C; Wiecha C; Kunzmann R; Heger U; Weichert W; Langer R; Stange A; Blank S; Sisic L; Schmidt T; Lordick F; Jäger D; Grenacher L; Bruckner T; Büchler MW; Ott K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S905-14. PubMed ID: 26001861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma.
    Patel SH; Kooby DA; Staley CA; Maithel SK
    J Surg Oncol; 2013 Jun; 107(7):728-34. PubMed ID: 23450704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria.
    Ellis FH; Heatley GJ; Krasna MJ; Williamson WA; Balogh K
    J Thorac Cardiovasc Surg; 1997 May; 113(5):836-46; discussion 846-8. PubMed ID: 9159617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of major postoperative complications and survival for locally advanced esophageal carcinoma patients.
    Sunpaweravong S; Ruangsin S; Laohawiriyakamol S; Mahattanobon S; Geater A
    Asian J Surg; 2012 Jul; 35(3):104-9. PubMed ID: 22884266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Postoperative respiratory failure in patients with cancer of esophagus and gastric cardia].
    Mao YS; Zhang DC; He J; Zhang RG; Cheng GY; Sun KL; Wang LJ; Yang L
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):753-6. PubMed ID: 16483491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinoma.
    van der Sluis PC; Ubink I; van der Horst S; Boonstra JJ; Voest EE; Ruurda JP; Borel Rinkes IH; Wiezer MJ; Schipper ME; Siersema PD; Los M; Lolkema MP; van Hillegersberg R
    Ann Surg Oncol; 2015 May; 22(5):1555-63. PubMed ID: 25564156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adenocarcinomas of the distal esophagus and cardia: surgical management].
    Triboulet JP; Fabre S; Castel B; Toursel H
    Cancer Radiother; 2001 Nov; 5 Suppl 1():90s-97s. PubMed ID: 11797291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
    Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
    G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.